Topical Compositions

JP2023550958A5Active Publication Date: 2024-11-11DSM IP ASSETS BV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023530845
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-27
Filing Date
2021-11-26
Publication Date
2024-11-11
Estimated Expiration
2041-11-26

AI Technical Summary

Technical Problem

Existing sunscreens with high SPF levels using inorganic UV filters like titanium dioxide and zinc oxide often result in a heavy, rough feel and a white/blue residue on the skin, while organic UV filters face safety concerns and consumer dissatisfaction.

Method used

A topical composition combining bisethylhexyloxyphenolmethoxyphenyltriazine (BEMT) and butyloctyl salicylate with inorganic UV filters, particularly double-coated titanium dioxide, reduces the whitening effect without using isoamyl p-methoxycinnamate, diethylaminohydroxybenzoylhexylbenzoate, and octocrylene, enhancing skin feel and appearance.

Benefits of technology

The composition achieves high SPF levels with reduced whitening and improved aesthetic properties, providing a more appealing skin feel and appearance compared to traditional formulations.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to certain topical compositions comprising bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), butyloctyl salicylate, and at least one inorganic UV filter selected from titanium dioxide and zinc oxide, which exhibit attractive skin feel and appearance.
Need to check novelty before this filing date? Find Prior Art

Description

Detailed description of the invention

[0001] The present invention relates to a specific topical composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), butyl octyl salicylate, and at least one inorganic UV filter selected from titanium dioxide and zinc oxide. The composition exhibits an attractive skin feel and appearance.

[0002] To provide effective protection against UV rays, there is a growing need for sunscreens with an SPF (Sun Protection Factor) of 20 or higher. However, at the same time, such sunscreens also need to exhibit an even more attractive skin feel and appearance.

[0003] Inorganic UV filters, namely finely powdered (often also called micronized) metal oxides such as titanium dioxide or zinc oxide, are particularly useful in sunscreen applications due to their ability to increase the sun protection factor (SPF) of formulations across a wide UV range. In addition, these inorganic UV filters are generally considered safe for cosmetic use and do not suffer from the sticky skin feel often associated with organic UV filters. Nevertheless, problems associated with the use of such inorganic UV filters still exist. In particular, the level of metal oxide powder required to achieve adequate (and higher) SPF levels can make the product aesthetically unacceptable, resulting in a heavy, gritty feel and a white / blue residue on the skin.

[0004] Attempts have been made to develop effective sunscreen compositions containing inorganic UV filters with low whitening properties, but this problem remains unresolved to the greatest extent possible, especially for formulations characterized by high sun protection indices.

[0005] Therefore, there is a continuing need to develop novel sunscreen formulations that exhibit low whitening effects while having a high sun protection index (SPF 20 or higher), containing an inorganic UV filter, and free from isoamyl 4-methoxycinnamate (INCI: p-isoamyl methoxycinnamate, CAS number 71617-10-2), 4-(dimethylamino)benzoic acid (2-ethylhexyl) ester (INCI: diethylamino hydroxybenzoyl hexyl benzoate; CAS number 302776-68-7), and ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene, CAS number 6197-30-4).

[0006] The downside of using deductible UV filters is that, despite approval by regulatory authorities, they are not without controversy for various reasons, such as potential hormonal activity, discoloration of formulations, or staining of fabrics, leading to downgrades in consumer magazines (e.g., EcoTest).

[0007] Surprisingly, butyloctyl salicylate and / or bis-ethylhexyloxyphenol methoxyphenyl triazine were found to reduce the whitening effect of inorganic UV filters in high-SPF formulations that do not contain isoamyl p-methoxycinnamate, diethylamino hydroxybenzoyl hexyl benzoate, and octocrylene. This effect is particularly pronounced when BHB and BEMT are used in combination, respectively, and the inorganic filter is titanium dioxide, most preferably a double-coated titanium dioxide containing an inner silica and an outer dimethicone coating.

[0008] Accordingly, in the first embodiment, the present invention provides a composition comprising bisethylhexyloxyphenol methoxyphenyl triazine (BEMT), butyloctyl salicylate (BHB), and at least one inorganic UV filter selected from titanium dioxide and zinc oxide (but not including isoamyl p-methoxycinnamate, diethylamino hydroxybenzoyl hexyl benzoate, and octocrylene).

[0009] Another subject of the present invention is a method for reducing the whitening effect caused by an inorganic UV filter selected from titanium dioxide and / or zinc oxide in a topical composition containing bisethylhexyloxyphenol methoxyphenyl triazine, particularly when applied to a surface such as skin, the method comprising the steps of adding butyloctyl salicylate to the topical composition, and optionally the step of evaluating the effect. Preferably, the composition does not contain any of p-methoxycinnamate isoamyl, diethylaminohydroxybenzoyl hexyl benzoate, and octocrylene.

[0010] In further embodiments, the present invention relates particularly to the use of butyloctyl salicylate to reduce the (skin) whitening effect of inorganic UV filters selected from titanium dioxide and zinc oxide when incorporated into topical compositions in combination with bisethylhexyloxyphenol methoxyphenyl triazine. Preferably, the composition does not contain any of p-methoxycinnamate isoamyl, diethylaminohydroxybenzoyl hexyl benzoate, and octocrylene.

[0011] The present invention also relates to the use of butyloctyl salicylate in combination with bisethylhexyloxyphenol methoxyphenyl triazine to reduce the (skin) whitening effect of inorganic UV filters selected from titanium dioxide and zinc oxide.

[0012] As used herein, the term “topical use” is understood to mean external application to the skin, scalp, eyelashes, eyebrows, nails, mucous membranes and hair, preferably to the keratinized material of the skin.

[0013] Bis-ethylhexylphenol methoxyphenyl triazine (hereinafter also referred to as BEMT) is also known as 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (chemical name) or bemotoridinol (INN) (CAS number 187393-00-6). BEMT acts as a broad-spectrum UV filter that absorbs UVB and UVA rays. It has two absorption peaks, 310 and 340 nm. BEMT has been proposed for use in sun products, daycare products, alphabet products such as BB creams, whitening products, and color cosmetics.

[0014] In all embodiments of the present invention, the amount of BEMT in the topical composition according to the present invention is advantageously selected from the range of 0.4 to 10% by weight, preferably 0.4 to 9% by weight, 0.4 to 8% by weight, 0.4 to 7% by weight, 0.4 to 6% by weight, 0.4 to 5% by weight, 0.4 to 4% by weight, 0.4 to 3% by weight, 0.5 to 3% by weight, 0.8 to 9% by weight, 0.8 to 8% by weight, 0.8 to 7% by weight, 0.8 to 6% by weight, 0.8 to 5% by weight, 0.8 to 4% by weight, or 0.8 to 3% by weight, for example, from the range of 1 to 5% by weight, 1 to 3% by weight, 2 to 5% by weight, or 2 to 4% by weight.

[0015] Butyl octyl salicylate (also referred to herein as BHB) is also known as 2-butyl octyl 2-hydroxybenzoate (CAS number: 190085-41-7). BHB commonly acts as a solubilizer for several commonly used UV filters, such as oxybenzone or avobenzone, and may also help increase the SPF value of sunscreens.

[0016] In all embodiments of the present invention, the amount of BHB in the topical composition according to the present invention is advantageously selected from the range of 0.5 to 10% by weight, preferably 0.5 to 9% by weight, 0.5 to 8% by weight, 0.5 to 7% by weight, 0.5 to 6% by weight, 0.5 to 5% by weight, 1 to 9% by weight, 1 to 8% by weight, 1 to 7% by weight, 1 to 6% by weight, 2 to 9% by weight, 2 to 8% by weight, 2 to 6% by weight, for example, from the range of 2.5 to 5% by weight, 2 to 3% by weight, or 2 to 5% by weight.

[0017] As used herein, the term “inorganic UV filter” refers to any metal oxide particles having a particle size that enables the absorption of UV light and is therefore useful for incorporation into sunscreen compositions as a UV filter. Such inorganic UV filters are well known to those skilled in the art and are often referred to as pulverized or fine titanium dioxide or zinc oxide.

[0018] The particle size of such inorganic UV filters is not particularly limited. Generally, a suitable (primary) particle size for efficient UV light absorption is in the range of 2 to 200 nm.

[0019] Unless otherwise specified, particle size as expressed herein refers to the median diameter Dn50 (also known as Dn0.5) of the number-based particle size distribution, determined, for example, by laser diffraction using a Horiba LA-960 particle size distribution analyzer or a Malvern Mastersizer 2000 (ISO 13320:2009).

[0020] In all embodiments of the present invention, the amount of inorganic UV filter in the topical composition is preferably selected from the range of 0.5 to 25% by weight, more preferably from 1 to 20% by weight, and most preferably from 2 to 15% by weight, based on the total weight of the composition. Further preferred amounts are selected from the ranges of 1 to 7% by weight, 2 to 7% by weight, 3 to 7% by weight, 1 to 6% by weight, 2 to 6% by weight, and 3 to 6% by weight.

[0021] More advantageously, the amount of inorganic titanium dioxide UV filter in the topical composition according to the present invention is selected from a range of 0.5 to 15% by weight, preferably 1 to 15% by weight, more preferably 2 to 10% by weight, and most preferably 2 to 6% by weight or 3 to 6% by weight, based on the total weight of the topical composition.

[0022] More advantageously, the amount of inorganic zinc oxide UV filter in the topical composition according to the present invention is selected from the range of 0.5 to 25% by weight, preferably 1 to 15% by weight, more preferably 2 to 15% by weight, and most preferably 5 to 15% by weight or 7.5 to 15% by weight, based on the total weight of the topical composition.

[0023] According to the present invention, it is advantageous for the inorganic UV filter to have a surface coating. The surface coating may include providing a thin hydrophilic or hydrophobic inorganic or organic layer on the metal oxide particles by a method known in itself. According to the present invention, various surface coatings may also include water. By surface treatment, hydrophilic, amphiphilic, or hydrophobic properties are imparted to the metal oxide.

[0024] Examples of inorganic surface coatings suitable for the purposes of the present invention include aluminum oxide (Al2O3), aluminum hydroxide Al(OH)3, aluminum oxide hydrate (also known as alumina, CAS number 1333-84-2), sodium hexametaphosphate (NaPO3)6, and sodium metaphosphate (NaPO3). n These include silicon dioxide (SiO2) (also known as silica, CAS number: 7631-86-9) and iron oxide (Fe2O3). These inorganic surface coatings may exist alone, in combination, and / or in combination with organic coating materials.

[0025] Examples of organic surface coatings suitable for use in the present invention include aluminum stearate of vegetable or animal origin, fatty acids such as stearic acid and lauric acid, dimethylpolysiloxane (also known as dimethicone), methylpolysiloxane (methicone), simethicone, triethoxycaprylylsilane, octyltrimethoxysilane, and cetyl phosphate such as potassium cetyl phosphate, and any mixtures thereof. These organic surface coatings can be present alone, in combination, and / or in combination with inorganic coating materials.

[0026] The crystal form of titanium dioxide can be any crystalline form or any amorphous form. For example, titanium dioxide can be of any type of amorphous, rutile, anatase, brookite, or mixtures thereof. In all embodiments of the present invention, the rutile crystal form of titanium dioxide is preferred.

[0027] Furthermore, zinc oxide is preferably a white powder composed of zinc oxide existing as a wurtzite-type crystal structure.

[0028] Titanium dioxide particles and predispersed titanium dioxide particles for use according to the present invention are available, for example, from DSM Nutritional Products Ltd. as PARSOL® TX (INCI: titanium dioxide, silica, dimethicone), from Tayca as Micro titanium dioxide MT-01, or from Ishihara Sangyo Co., Ltd. as TTO-55(C). Also suitable is double-coated titanium dioxide having an inner alumina coating and an outer simethicone coating (for example, commercially available as Eusolex T-2000 from EMD chemicals Inc / Rona).

[0029] Zinc oxide particles and pre-dispersions of zinc oxide particles for use according to the present invention are available, for example, from BASF as Z-Cote or Z-Cote HP1 (2% dimethicone coating), from Tayca as MZ-505S (5% methicone coating), or from DSM Nutritional Products Ltd as PARSOL® ZX (2-3.5% triethoxycaprylylsilane coating).

[0030] In certain embodiments, the topical composition according to the present invention comprises, as an inorganic UV filter, double-coated titanium dioxide and / or coated zinc oxide, most preferably in the absence of further fine metal oxides.

[0031] Most preferably, in all embodiments of the present invention, the titanium dioxide is double-coated titanium dioxide, and more preferably, double-coated titanium dioxide having an inner silica coating and an outer organic coating.

[0032] The inner silica coating layer of the double-coated titanium dioxide preferably consists of at least 0.5% by weight of inorganic silica (based on titanium dioxide). More preferably, the inner coating layer consists of 0.5% to 50% by weight of inorganic silica (based on titanium dioxide), most preferably 1% to 20% by weight.

[0033] The outer coating of the double-coated titanium dioxide is preferably selected from a class of organic coatings, such as silicone oil (e.g., simethicone, methicone, dimethicone, polysilicone-15), alkylsilane (e.g., octyltri(me)ethoxysilane), olefinic acid (e.g., stearic acid), or polyol (e.g., glycerol), and can be applied to the titanium dioxide particles by methods known to those skilled in the art, for example, the method described in FI57124. The outer coating is preferably selected from the group consisting of simethicone, methicone, dimethicone, polysilicone-15, stearic acid, and octyltrimethoxysilane. The outer coating is most preferably dimethicone. More preferably, the amount of the outer coating layer is at least 0.25% by weight based on titanium dioxide. The amount of the outer coating is preferably selected in the range of 0.5% to 50% by weight, most preferably in the range of 0.5% to 10% by weight, based on titanium dioxide.

[0034] In all embodiments of the present invention, the double-coated titanium dioxide according to the present invention preferably has a titanium dioxide content selected from the range of 70 to 95% by weight and a silicon dioxide content selected from the range of 5 to 20% by weight, for example, preferably a titanium dioxide content selected from the range of 80 to 90% by weight and a silicon dioxide content selected from the range of 10 to 15% by weight (provided that the total content of titanium dioxide and silicon dioxide is selected from the range of 90 to 100% by weight).

[0035] Preferably, the double-coated titanium dioxide has an average primary particle size in the range of 2 to 100 nm, more preferably in the range of 5 to 50 nm, and most preferably in the range of 10 to 25 nm, and a secondary particle size of 0.025 to 1 μm, for example, preferably 0.05 to 0.075 μm.

[0036] A particularly suitable double-coated titanium dioxide according to the present invention contains a rutile-type titanium dioxide (TiO2) core having a double coating of silica (inner coating) and dimethicone (outer coating), and has a titanium dioxide content in the range of at least 75% by weight, preferably 82-87% by weight, and a silicon dioxide content in the range of at least 10% by weight, preferably 10.5-14.5% by weight, and an average particle size distribution D of 25-100 nm, preferably 40-80 nm. n It has a molecular weight of 50 (analyzed by laser diffraction measurement using Malvern Mastersizer 2000), and this double-coated titanium dioxide is commercially available, for example, from DSM nutritional products Ltd as PARSOL® TX (INCI: titanium dioxide, silica, dimethicone).

[0037] In all embodiments of the present invention, zinc oxide is most preferably coated with triethoxycaprylylsilane. The zinc oxide is a white powder consisting of zinc oxide existing as a wurtzite-type crystalline structure coated with triethoxycaprylylsilane, with a zinc oxide content of 96-98%, a triethoxycaprylylsilane content of 2-3.5%, and an average particle size of 90-130 nm (analyzed by laser diffraction measurement using Malvern Mastersizer 2000).

[0038] In particularly advantageous embodiments, the composition according to the present invention does not contain ethylhexyl salicylate. More preferably, the composition according to the present invention comprises only bisethylhexyloxyphenol methoxyphenyl triazine, butyl octyl salicylate, and at least one inorganic UV filter selected from titanium dioxide and zinc oxide as a UV absorber. That is, no further UV filters are present in the composition.

[0039] Since the topical compositions according to the present invention are intended for topical application, it is well understood that they include physiologically acceptable media, i.e., media compatible with keratinous materials such as skin, mucous membranes, and keratin fibers. In particular, physiologically acceptable media are cosmetically acceptable carriers.

[0040] As used herein, the term “cosmetically acceptable carrier” refers to all carriers and / or excipients and / or diluents conventionally used in topical cosmetic compositions, particularly skincare formulations.

[0041] The exact amount of the carrier will depend on the actual amounts of the UV filter and all other optional components (e.g., other active ingredients) that a person skilled in the art would classify as distinct from the carrier.

[0042] In advantageous embodiments, the topical composition according to the present invention comprises, based on the total weight of the topical composition, a carrier of the form of 50% to 99%, preferably 60% to 98%, more preferably 70% to 98%, and particularly 80% to 95%.

[0043] In particularly advantageous embodiments, the carrier further comprises at least 30% by weight, more preferably at least 40% by weight, most preferably at least 45% by weight of water, and especially 50-90% by weight of water.

[0044] In particular, the topical composition according to the present invention is a cosmetic or pharmaceutical composition, preferably a cosmetic (non-therapeutic) composition.

[0045] In one embodiment, the topical composition according to the present invention is applied particularly to the keratinized tissue of mammals such as human skin or human scalp and hair.

[0046] As used in this application, the term “cosmetic composition” refers to the cosmetic composition as defined under the heading “Kosmetika” in Roempp Lexikon Chemie, 10th edition 1997, Georg Thieme Verlag Stuttgart, New York, and the cosmetic composition disclosed in A. Domsch, “Cosmetic Compositions”, Verlag fuer chemische Industrie (ed. H. Ziolkowsky), 4th edition, 1992.

[0047] Preferred topical compositions according to the present invention include skincare formulations, cosmetic formulations, and functional formulations.

[0048] Examples of skincare formulations include, in particular, photoprotective formulations, anti-aging formulations, formulations for treating photoaging, body oils, body lotions, body gels, treatment creams, skin protective ointments, skin powders, moisturizing gels, moisturizing sprays, moisturizers for face and / or body, tanning formulations (i.e., compositions for artificially tanning and / or browning human skin without the use of sunlight), such as self-tanning creams, and skin whitening formulations.

[0049] Examples of cosmetic formulations include, in particular, lipstick, eyeshadow, mascara, dry and wet makeup formulations, blush, and / or powder.

[0050] Examples of functional formulations include, but are not limited to, cosmetics or pharmaceutical compositions containing active ingredients such as hormone preparations, vitamin preparations, plant extract preparations, anti-aging preparations, and / or antimicrobial (antibacterial or antifungal) preparations.

[0051] In certain embodiments, the topical compositions according to the present invention are photoprotective formulations (sun care products, sunscreens) such as UV-protective emulsions, UV-protective lotions, UV-protective creams, UV-protective oils, UV-blocking agents, or tropical or daycare creams having an SPF (Sun Protection Factor). Of particular interest are UV-protective creams, UV-protective lotions, and UV-protective emulsions.

[0052] The compositions of the present invention (including carriers) may contain conventional auxiliaries and additives such as preservatives / antioxidants, fatty substances / oils, organic solvents, silicones, thickeners, softeners, emulsifiers, defoamers, fragrances, surfactants, fillers, anionic, cationic, nonionic or amphoteric polymers or mixtures thereof, propellants, acidifying or basicizing agents, dyes, colorants, abrasives, absorbents, chelating agents and / or metal ion sequestering agents, essential oils, skin coolants, astringents, pigments, or any other components commonly incorporated into such compositions.

[0053] According to the present invention, the composition according to the present invention may include components for skin whitening, sun protection, treatment of hyperpigmentation, preventing or reducing acne, wrinkles, fine lines, atrophy and / or inflammation, chelating agents and / or metal ion sequestering agents, anti-pigmentation and slimming agents (e.g., phytanic acid), firming agents, moisturizing and activating agents, self-tanning agents, sedatives, and agents for improving elasticity and skin barrier properties, and / or further UV filtering substances, as well as further components such as carriers and / or excipients or diluents conventionally used in topical compositions.

[0054] Unless otherwise specified, the excipients, additives, diluents, etc. described below are suitable for topical compositions according to the present invention. The required amounts of cosmetic and dermatological auxiliaries and additives can be easily determined by those skilled in the art based on the desired product.

[0055] Additional components may be added to the oily phase, the aqueous phase, or separately, if deemed appropriate. The method of addition can be easily adapted by those skilled in the art.

[0056] Examples of cosmetic excipients, diluents, auxiliaries, additives, and active ingredients commonly used in the skincare industry and suitable for use in the cosmetic compositions of the present invention are, for example, listed in the International Cosmetic Ingredient Dictionary & Handbook by the Personal Care Product Council (http: / / www.personalcarecouncil.org / ), which is available online at INFO BASE (http: / / online.personalcarecouncil.org / jsp / Home.jsp), but are not limited to those listed therein.

[0057] In this specification, useful cosmetic active ingredients may, in some cases, provide two or more benefits or act through two or more mechanisms of action.

[0058] Naturally, those skilled in the art will select the above-mentioned optional additional components, auxiliaries, diluents, and additives, and / or their amounts, taking into consideration that the advantageous properties inherently associated with the combinations according to the present invention are not adversely affected or substantially adversely affected by one or more of the assumed additions.

[0059] Preferred cosmetic compositions in all embodiments of the present invention are emulsions containing an oil phase and an aqueous phase, particularly O / W, W / O, Si / W, W / Si, O / W / O, W / O / W multi-layer or Pickering emulsions. The amount of the oily phase (i.e., the phase containing all oils and fats) present in such an emulsion is preferably at least 10% by mass, for example, in the range of 10 to 60% by mass, preferably 15 to 50% by mass, and most preferably 15 to 40% by mass, based on the total weight of the topical composition.

[0060] In a more preferred embodiment, the topical composition according to the present invention outlined herein is an O / W emulsion comprising an oil phase dispersed in an aqueous phase in the presence of an O / W emulsifier. The preparation of such O / W emulsions is well known to those skilled in the art and is illustrated in the examples.

[0061] In one advantageous embodiment, the O / W emulsifier is a phosphate ester emulsifier. Preferred phosphate ester emulsifiers include C8-10 alkyl ethyl phosphates, C9-15 alkyl phosphates, ceteareth-2 phosphate, ceteareth-5 phosphate, ceteth-8 phosphate, ceteth-10 phosphate, cetyl phosphate, C6-10 pareth-4 phosphate, C12-15 pareth-2 phosphate, C12-15 pareth-3 phosphate, ceteareth-2 phosphate DEA, cetyl phosphate DEA, oleth-3 phosphate DEA, potassium cetyl phosphate, deceth-4 phosphate, deceth-6 phosphate, and trilaureth-4 phosphate. A specific phosphate ester emulsifier according to the present invention is, for example, potassium cetyl phosphate, which is commercially available from DSM Nutritional Products Ltd Kaiseraugst as Amphisol® K.

[0062] Further preferred O / W emulsifiers according to the present invention include PEG-30 dipolyhydroxystearate, PEG-4 dilaurate, PEG-8 dioleate, PEG-40 sorbitol oleate, PEG-7 glyceryl cocoate, PEG-20 glyceryl almond oil, PEG-25 hydrogenated castor oil, glyceryl stearate (and) PEG-100 stearate, PEG-7 olivine oil fatty acid, PEG-8 oleate, PEG-8 laurate, PEG-60 glyceryl almond oil, PEG-20 methyl glucose sesquistearate, PEG-40 stearate, and P stearate. Contains EG-100, PEG-80 sorbitan laurate, steareth-2, steareth-12, oleth-2, ceteth-2, laureth-4, oleth-10, oleth-10 / polyoxyethylene(10) oleyl ether, ceteth-10, isosteareth-20, ceteareth-20, oleth-20, steareth-20, steareth-21, ceteth-20, isoceteth-20, laureth-23, steareth-100, glyceryl stearate citrate, glyceryl stearate (self-emulsifying type), stearic acid, salts of stearic acid, and polyglyceryl-3 methyl glucose distearate. Further preferred emulsifiers include sorbitan oleate, sorbitan sesquioleate, sorbitan isostearate, sorbitan trioleate, lauryl glucoside, decyl glucoside, sodium stearoyl glutamate, sucrose polystearate, and hydrated polyisobutene. In addition, one or more synthetic polymers can be used as emulsifiers. For example, (PVP / eicosene) copolymer, (acrylates / alkyl acrylate (C10-30)) crosspolymer, (acrylates / steareth-20 methacrylate) copolymer, (PEG-22 / dodecyl glycol) copolymer, (PEG-45 / dodecyl glycol) copolymer, and mixtures thereof.

[0063] Other particularly suitable types of O / W emulsifiers include nonionic self-emulsifying systems derived from olive oil, such as (INCI name) cetearyl olive oil fatty acid and sorbitan olive oil fatty acid (chemical composition: sorbitan ester and cetearyl ester of olive oil fatty acid), which are sold under the trade name OLIVEM 1000.

[0064] More preferably are commercially available polymer emulsifiers, such as hydrophobic modified polyacrylic acids like (acrylates / alkyl acrylate (C10-30)) crosspolymers sold by Noveon under the trade names Pemulen® TR-1 and TR-2.

[0065] Other particularly suitable types of emulsifiers are polyglycerol esters or diesters of fatty acids (i.e., polymers in which fatty acids are bonded by esterification with polyglycerol), also known as polyglyceryl esters / diesters, such as Isolan GPS [INCI name (diisostearate / polyhydroxystearate / sebacic acid) polyglyceryl-4 (i.e., a diester of a mixture of isostearate, polyhydroxystearate and sebacic acid with polyglycerol-4)], commercially available from Evonik, or Dehymuls PGPH [INCI polyglyceryl-2 dipolyhydroxystearate], commercially available from Cognis.

[0066] Polyethylene glycol ethers such as Brij 72 (polyoxyethylene(2) stearyl ether) or Brij 721 (polyoxyethylene(21) stearyl ether), available from Croda, are also suitable.

[0067] Particularly advantageous O / W emulsifiers according to the present invention include polyglyceryl-3 methyl glucose distearate, lauryl glucoside (and) polyglyceryl-2 dipolyhydroxystearate, glyceryl stellate cytrate, sodium cetearyl sulfate, cetearyl glucoside; polyglyceryl-6 stearate (and) polyglyceryl-6 behenate, cetearyl olivate (and) sorbitan olivate, arachidyl alcohol (and) One or more of the following: behenyl alcohol (and) arachidyl glucoside, cetearyl alcohol (and) coconut oil alkyl glucoside, coconut oil alkyl glucoside (and) coconut alcohol, PEG-100 stearate (and) glyceryl stearate, sodium stearoyl glutamate, steareth-20, steareth-21, steareth-25, steareth-2, ceteareth-25, and ceteareth-6 (all listed by their INCI names).

[0068] According to the present invention, it is particularly preferable that the composition contains potassium cetyl phosphate as an emulsifier.

[0069] This at least one O / W or Si / W emulsifier is preferably used in an amount ranging from 0.5 to 10% by weight, particularly 0.5 to 5% by weight, and most particularly 0.5 to 4% by weight, based on the total weight of the composition.

[0070] Suitable W / O or W / Si emulsifiers according to the present invention include polyglyceryl-2-dipolyhydroxystearic acid, PEG-30 dipolyhydroxystearic acid, cetyl dimethicone copolyol, polyglyceryl-3 diisostearate polyglycerol ester of oleic acid / isostearate, polyglyceryl-6 hexalicinoleate, polyglyceryl-4 oleate, polygylceryl-4 oleate / PEG-8 propylene glycol cocoate, magnesium stearate, sodium stearate, potassium laurate, potassium ricinoleate, sodium cocoate, sodium tallowate, potassium castrate, sodium oleate, and mixtures thereof. Further preferred W / Si emulsifiers are lauryl polyglyceryl-3 polydimethylsiloxyethyl dimethicone, and / or PEG-9 polydimethylsiloxyethyl dimethicone, and / or cetyl PEG / PPG-10 / 1 dimethicone, and / or PEG-12 dimethicone crosspolymer, and / or PEG / PPG-18 / 18 dimethicone. At least one W / O emulsifier is used in an amount preferably about 0.001 to 10% by weight, more preferably 0.2 to 7% by weight, based on the total weight of the composition.

[0071] According to the present invention, it is also advantageous that the formulation of the present invention does not contain polyethylene glycol, polyethylene glycol ether, and polyethylene glycol ester (so-called PEG derivatives).

[0072] The topical compositions according to the present invention are further advantageous in containing at least one surfactant selected from the group of monoglycerides, diglycerides, and / or fatty alcohols. The surfactant is generally used in an amount selected from the range of 0.1 to 10% by weight, particularly 0.5 to 7% by weight, and most particularly 1 to 5% by weight, based on the total weight of the composition. Particularly preferred surfactants are selected from the list of alkyl alcohols such as cetyl alcohol (Lorol C16, Lanette 16), cetearyl alcohol (Lanette O), stearyl alcohol (Lanette 18), behenyl alcohol (Lanette 22), glyceryl stearate, glyceryl myristate (Estol 3650), hydrogenated cocoglycerides (Lipocire Na10), and mixtures thereof.

[0073] In all embodiments of the present invention, it is particularly advantageous if the composition also contains cetyl alcohol, stearyl alcohol and / or glyceryl stearate, preferably stearyl alcohol.

[0074] As an advantageous embodiment of the composition of the present invention, the composition comprises di(caprylic / capric acid)butylene glycol, phenethyl benzoate, and alkyl benzoate (C 12 ~C 15 ), dibutyl adipate, diisopropyl sebacate, dicaprylyl carbonate, dialkyl (C) tartrate 12~13 ), butyloctyl salicylate, diethylhexyl syringylidene malonate, hydrogenated castor oil dimer acid, triheptanoin, alkyl lactate (C 12~13 Embodiments also include one or more oils selected from ), alkyl benzoate (C16-17), propylheptyl caprylate, caprylic / capric triglyceride, 2,6-naphthalenedicarboxylate diethylhexyl, octyldodecanol, and coconut oil fatty acid ethylhexyl. Preferably, the composition according to the present invention includes, as the oil, dibutyl adipate, dicaprylyl carbonate, alkyl benzoate (C 12 ~C 15) Caprylyl carbonate, tri (capric acid / caprylic acid) glyceride, and mixtures thereof, most preferably dibutyl adipate, dicaprylyl carbonate and / or benzoic acid C 12 ~C 15 alkyl.

[0075] In a further advantageous embodiment of the present invention, the topical composition of the present invention preferably further comprises a preservative and / or a co-preservative selected from the group consisting of ethanol, phenoxyethanol, ethylhexylglycerin, hexylglycerin, glyceryl caprylate, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol (caprylyl glycol), 1,2-decanediol, 2-methyl-1,3-propanediol, propylene glycol, p-hydroxyacetophenone and mixtures thereof, most preferably selected from the group consisting of phenoxyethanol and ethylhexylglycerin and mixtures thereof. When a preservative or a co-preservative is included, they are preferably used in an amount of 0.01 to 2% by weight, more preferably 0.05 to 1.5% by weight, most preferably 0.1 to 1.0% by weight based on the total weight of the composition.

[0076] According to the present invention, it is advantageous for the formulation to contain one or more alkanediols from the group of 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl-1,3-propanediol.

[0077] Furthermore, according to the present invention, it is advantageous for the composition of the present invention to contain ethanol, p-hydroxyacetophenone, phenoxyethanol and / or ethylhexylglycerin.

[0078] In another advantageous embodiment, the topical composition according to the present invention does not contain any parabens, benzethonium chloride, piroctone olamine, lauroylarginate, methylisothiazolinone, chloromethylisothiazolinone, bronopol, benzalkonium chloride, formaldehyde-releasing compounds, salicylic acid, triclosan, DMDM ​​hydantoin, chlorphenesin, or IPBC (iodopropynyl butylcarbamate).

[0079] The topical composition according to the present invention may further contain one or more emollients that soothe and soften the skin. For example, the emollients may be silicones (dimethicone, cyclomethicone), vegetable oils (grape seed oil, sesame seed oil, jojoba oil, etc.), butters (cocoa butter, shea butter), and petrolatum derivatives (petrolatum, mineral oil).

[0080] In other embodiments, the topical compositions of the present invention include limonene, citral, linalool, alpha-isomethyl ionone, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetraline, diester adipates, cinnamal, amyl salicylate, alpha-amyl cinnamaldehyde, alpha-methyl ionone, butylphenyl methylpropional, cinnamal, amyl cinnamyl alcohol, anise alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, salicylate It may contain one or more fragrances selected from benzyl benzoate, bergamot oil, bitter orange oil, butylphenyl methylpropional, cardamom oil, cedrol, cinnamal, cinnamyl alcohol, citronellyl methylcrotate, citrus oil, coumarin, diethyl succinate, ethyl linalool, eugenol, Ebernia furfrasea extract, hornwort extract, farnesol, guaiawood oil, hexyl cinnamal, hexyl salicylate, hydroxycitronellal, lavender oil, lemon oil, linalyl acetate, mandarin oil, PCA menthyl, methylheptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate, and vanillin.

[0081] The compositions of the present invention may, advantageously, include humectants. The humectants are compounds or mixtures of compounds that, after the cosmetic formulation is applied to or spread on the skin surface, impart to the cosmetic composition a quality that reduces water loss from the stratum corneum (also known as transepidermal water loss (TEWL)) and / or has a favorable effect on the hydration of the stratum corneum.

[0082] Non-limiting examples of humectants advantageous for use in the present invention include glycerol, lactic acid and / or lactates, particularly sodium lactate, butylene glycol, propylene glycol, biosaccharide gum-1, soybean extract, ethylhexyloxyglycerol, pyrrolidone carboxylic acid, and urea. It is particularly advantageous to use high molecular weight humectants from the group of polysaccharides that are water-soluble and / or water-swellable and / or gellable by the power of water. Particularly advantageous are, for example, hyaluronic acid, chitosan, and / or fucose-rich polysaccharides, the fucose-rich polysaccharides being registered in Chemical Abstracts under registration number 178463-23-5 and available, for example, from SOLABIAS.A. under the name Fucogel® 1000. Humidifiers can also be advantageously used, for example, as anti-wrinkle active ingredients to protect the skin from the types of changes caused by skin aging.

[0083] While not essential, advantageously, the cosmetic formulations of the present invention may further include fillers that, for example, further improve the perceptual and cosmetic properties of the formulation and have the effect of evoking or emphasizing a velvety or silky skin feel. Advantageous fillers in the sense of the present invention include starch and starch derivatives (e.g., tapioca starch, cross-linked starch phosphate, aluminum starch octenyl succinate, sodium starch octenyl succinate, etc.), Valvance pigments that essentially do not exhibit UV filtering or coloring effects (e.g., Valvance Touch 210 or Valvance Touch 250), and / or Aerosils® (CAS No. 7631-86-9), and / or talc, and / or polyethylene, nylon, and dimethylsilylated silica.

[0084] The aqueous phase of the composition of the present invention may, advantageously, include commonly used cosmetic additives, for example, individually or in combination in each case, alcohols, particularly those with a low number of carbon atoms, preferably ethanol and / or isopropanol or polyols with a low number of carbon atoms, in addition to their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanning agents, and in addition thereto, particularly one or more thickeners, advantageously silicon dioxide, aluminum silicate, polysaccharides and / or derivatives thereof, thickeners that can be selected from the group of hyaluronic acid, xanthan gum, hydroxypropyl methylcellulose, particularly advantageously polyacrylates, preferably thickeners from the group of polyacrylates called Carbopol (examples include 980, 981, 1382, 2984 and 5984 type carbopols). Further advantageous thickeners according to the present invention include those having the INCI name (Acrylates / Alkyl Acrylate (C10-30)) crosspolymer (e.g., Pemuren TR 1, Pemuren TR 2, Carbopol 1328 from Noveon), in addition to Aristoflex AVC (INCI: (Acryloyldimethyltaurate Ammonium / VP) Copolymer), and Simugel NS (INCI: (Hydroxyethyl Acrylate / Sodium Acryloyldimethyltaurate) Copolymer and Squalane and Polysorbate 60).

[0085] According to the present invention, the composition preferably comprises xanthan gum, (acrylate / alkyl acrylate (C10-C30) crosslinked polymer, (hydroxyethyl acrylate / sodium acryloyldimethyl taurate) copolymer, and / or (vinylpyrrolidone / hexadecene) copolymer, preferably xanthan gum and / or hydroxyethyl acrylate / sodium acryloyldimethyl taurate.

[0086] In addition to bisethylhexyloxyphenol methoxyphenyl triazine (BEMT) BHB and inorganic UV filters, one or more further UV filters may be included in the topical composition according to the present invention. These UV filters are, in particular, (INCI name) methylenebisbenzotriazolyltetramethylbutylphenol, trisbiphenyl triazine, phenylbenzimidazole sulfonic acid, dimethicone diethylbenzalmalonate, 4-methylbenzylidene camphor, ethylhexyl salicylate, homosalate, ethylhexyl triazone, diethylhexylbutamide triazone, butyl methoxydibenzoylmethane, disodium phenyldibenzimidazole tetrasulfonate, and oxybenzone, but are not limited thereto.

[0087] However, in an advantageous embodiment of the present invention, the topical composition according to the present invention further does not contain (i.e., does not contain) 3-(4-methylbenzylidene)campha (INCI: 4-methylbenzylidenecampha), 2-hydroxy-4-methoxybenzophenone (INCI: oxybenzone), and / or ethylhexyl methoxycinnamate.

[0088] The topical composition of the present invention requires a remarkably small total amount of UV filter.

[0089] In another embodiment, the composition may have at least 20, preferably at least 30 SPF.

[0090] According to the present invention, it is advantageous for the composition of the present invention to include a film-forming agent. A film-forming agent in the sense of the present invention is a substance having various compositions and is characterized by having the following properties. When the film-forming agent is dissolved in water or another suitable solvent and this solution is applied to the skin, the film-forming agent forms a film after the solvent evaporates, and this film essentially serves to fix a light-shielding substance to the skin and to enhance the water resistance of the product.

[0091] It is particularly advantageous to select a film-forming agent from the group of polymers based on polyvinylpyrrolidone (PVP).

[0092] For example, vinylpyrrolidone copolymers such as (PVP / hexadecene) copolymer and (PVP / eicosene) copolymer (these are available from GAF Chemicals Corporation under the trade names Antaron V216 and Antaron V220) are particularly preferred.

[0093] Similarly, other polymeric film-forming agents are also advantageous, such as sodium polystyrene sulfonate (available from National Starch and Chemical Corp. under the trade name Flexan 130) and / or polyisobutene (available from Rewo under the trade name Rewopal PIB1000). Further examples of suitable polymers include polyacrylamide (Seppigel 305), polyvinyl alcohol, PVP, (PVP / VA) copolymer, polyglycol, and (acrylate / octylacrylamide) copolymer (Dermacryl 79). It is equally advantageous to use hydrogenated castor oil dimer dilinoleate (CAS 646054-62-8, INCI hydrogenated castor oil dimer dilinoleate) (available from Higher Alcohol Industries Co., Ltd. under the name Risocast DA-H), or PPG-3 benzyl ether myristate (CAS 403517-45-3) (available from Croda Chemicals under the trade name Crodamol STS).

[0094] The topical compositions according to the present invention generally have a pH in the range of 3 to 10, preferably in the range of 4 to 8, and most preferably in the range of 4 to 7. The pH can be easily adjusted as needed by standard methods in the art using a suitable acid, such as citric acid, or a base such as NaOH.

[0095] According to the present invention, the composition of the present invention is used to protect the skin from aging (particularly from UV-induced skin aging), and also as an ultraviolet protection composition.

[0096] Finally, the subject matter of the present invention is a method for cosmetically treating keratinous substances, particularly skin, and the compositions defined above are particularly applicable to such keratinous substances, particularly skin. This method is particularly suitable for protecting the skin from the adverse effects of UV, such as sunburn and / or photoaging, while reducing the skin whitening effect of inorganic UV filters selected from the group of titanium dioxide and / or zinc oxide.

[0097] The following examples are provided to further illustrate the compositions and effects of the present invention. These examples are illustrative and are not intended to limit the scope of the present invention.

[0098] [Examples] [1. Example 1] The cream formulations outlined in Table 1a were prepared. Subsequently, the cream was applied to a Leneta card to a film thickness of 60 μm using a Rekel and a spreading speed of 10 mm / second, following the procedure below.

[0099] Subsequently, whitening was evaluated by measuring the L value (four cards for each formulation, measuring three spots on each card: 12 values / formulation). Explanation of L value: The higher the value, the whiter / bluish the film becomes.

[0100] [Table 1]

[0101] [Table 2]

[0102] As is clear from Table 2, the addition of BHB reduced the whitening of sunscreens containing BEMT and inorganic UV filters.

[0103] [2. Example 2] The formulations (O / W emulsions) outlined in Table 2 were prepared using standard methods in the relevant field. The soaping effect on LENTA Black Cards was then tested according to the method outlined below. - Apply 300mg of cream to the LENETA Black Card. - Using a proprietary spreading device with a 90mm spread knife (speed: 10mm / second), the cream is spread to a uniform film thickness. - LAB was measured immediately after application using a Minolta Chroma Meter CR-300 (3 measurement spots on each card; 4 cards were prepared). - Calculate and compare the average L value.

[0104] [Table 3]

[0105] As is clear from Table 2, the combination of BEMT, BHB, and TiO2 micropigments according to the present invention results in a significant decrease in L value, which reflects a reduction in the whitening effect of the composition.

[0106] [3. Example 3] The formulations (O / W emulsions) outlined in Table 3 were prepared using standard methods in the relevant technical field. Then, the whitening effect on LENTA Black Cards was tested according to the method outlined below. - Apply 300mg of cream to each LENETA Black Card (use 3 cards for each formulation). - A spreading device using a 60mm spread knife (speed: 10mm / second) is used to spread the cream to a uniform film thickness. - LAB is measured using the Minolta Chroma Meter CR-300 (3 measurement spots on each card). - Calculate and compare the average L value.

[0107] [Table 4]

[0108] As is clear from Table 3, the combination of BEMT, BHB, and ZnO micropigments according to the present invention results in a significant decrease in the L value, which reflects a reduction in the whitening effect of the composition.

Claims

1. A topical composition comprising bisethylhexyloxyphenol methoxyphenyl triazine, butyloctyl salicylate, and at least one inorganic UV filter selected from titanium dioxide and zinc oxide, with the proviso that the composition does not contain isoamyl p-methoxycinnamate, diethylamino hydroxybenzoyl hexyl benzoate, or 2-cyano-octocrylene ethylhexyl.

2. The topical composition of claim 1, wherein the amount of bis-ethylhexyloxyphenol methoxyphenyl triazine is selected in the range of 0.4 to 10% by weight.

3. 3. The topical composition according to claim 1 or 2, comprising butyloctyl salicylate in an amount selected in the range of 0.5 to 10% by weight, based on the total weight of the composition.

4. 4. The topical composition according to claim 1, comprising the inorganic UV filter in an amount selected in the range of 0.5 to 25% by weight, based on the total weight of the composition.

5. The topical composition according to any one of claims 1 to 4, wherein the inorganic UV filter is a surface coating.

6. 6. The topical composition according to any one of claims 1 to 5, wherein the inorganic UV filter is selected from double coated titanium dioxide having an inner silica coating and an outer dimethicone coating, and zinc oxide coated with triethoxycaprylylsilane, and mixtures thereof.

7. A topical composition according to any one of claims 1 to 6, which is an O / W emulsion comprising an oily phase dispersed in an aqueous phase in the presence of an O / W emulsifier.

8. Butylene glycol, dicaprylate / dicaprate, phenethyl benzoate, alkyl benzoate (C 12 --C 15 ), dibutyl adipate, diisopropyl sebacate, dicaprylyl carbonate, dialkyl tartrate (C 12 ~ 13 ), diethylhexyl syringylidene malonate, hydrogenated castor oil dimer acid, triheptanoin, alkyl lactate (C 12 ~ 13 ), alkyl benzoate (C 16~17 8. The topical composition of any one of claims 1 to 7, comprising one or more selected from the group consisting of propylheptyl caprylate, caprylic / capric triglyceride, diethylhexyl 2,6-naphthalene dicarboxylate, octyldodecanol, ethylhexyl cocoate, and dibutyl adipate.

9. The topical composition of any one of claims 1 to 8, comprising one or more of ethanol, p-hydroxyacetophenone, phenoxyethanol, and ethylhexylglycerin.

10. Xanthan gum, (acrylates / alkyl acrylates (C 10 ~C 30 10. The topical composition of any one of claims 1 to 9, comprising one or more of the following: (hydroxyethyl acrylate / sodium acryloyldimethyltaurate) crosslinked polymer; (hydroxyethyl acrylate / sodium acryloyldimethyltaurate) copolymer.

11. The topical composition of any one of claims 1 to 10, comprising one or more of cetyl alcohol, cetearyl alcohol, stearyl alcohol and glyceryl stearate.

12. 12. The topical composition according to any one of claims 1 to 11, comprising one or more alkanediols from the group: 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, propanediol, propylene glycol 2-methyl-1,3-propanediol.

13. The topical composition of any one of claims 1 to 12, having an SPF of at least 20.

14. 1. A method for reducing the whitening effect caused by an inorganic UV filter selected from titanium dioxide and / or zinc oxide in a topical composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine when applied to a surface, comprising the step of adding butyloctyl salicylate to the topical composition.

15. Use of butyloctyl salicylate in combination with bis-ethylhexyloxyphenol methoxyphenyl triazine to reduce the (skin) whitening effect of inorganic UV filters selected from titanium dioxide and zinc oxide.